Sanofi India Limited — Codeine Exporter Profile
Indian Pharmaceutical Exporter · #4 for Codeine · $3.8M export value · DGFT Verified
Sanofi India Limited is the #4 Indian exporter of Codeine with $3.8M in export value and 75 verified shipments. Sanofi India Limited holds a 3.4% market share in Codeine exports across 2 countries. The company exports 4 pharmaceutical products worth $9.0M across 4 therapeutic categories.
Sanofi India Limited — Codeine Export Profile: Buyers & Destinations
Where Does Sanofi India Limited Export Codeine?
Sanofi India Limited exports Codeine to 2 countries. The largest destination is AUSTRALIA accounting for 98.4% of Sanofi India Limited's Codeine shipments. These destinations reflect Sanofi India Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Codeine from Sanofi India Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SANOFI-AVENTIS AUSTRALIA PTY LTD | AUSTRALIA | $2.5M | 60 |
| SANOFI AVENTIS AUSTRALIA PTY LTD | AUSTRALIA | $300.0K | 6 |
| SANOFI-AVENTIS AUSTRALIA PTY LIMITED | AUSTRALIA | $259.8K | 8 |
| PHOENIX LABS C/O, | IRELAND | $50.0K | 1 |
Sanofi India Limited supplies Codeine to 4 buyers globally. The largest buyer is SANOFI-AVENTIS AUSTRALIA PTY LTD (AUSTRALIA), followed by SANOFI AVENTIS AUSTRALIA PTY LTD (AUSTRALIA) and SANOFI-AVENTIS AUSTRALIA PTY LIMITED (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Codeine Export Value and How Much Does Sanofi India Limited Contribute?
India exported $59.2M worth of Codeine through 1,785 shipments from 30 suppliers to 35 countries, serving 82 buyers globally. Sanofi India Limited contributes $3.8M to this total, accounting for 3.4% of India's Codeine exports. Sanofi India Limited ships Codeine to 2 countries through 4 buyers.
What Is the Average Shipment Value for Sanofi India Limited's Codeine Exports?
Sanofi India Limited's average Codeine shipment value is $50.0K per consignment, based on 75 shipments totaling $3.8M. The largest destination is AUSTRALIA (98.4% of Sanofi India Limited's Codeine exports).
How Does Sanofi India Limited Compare to Other Indian Codeine Exporters?
Sanofi India Limited ranks #4 among 30 Indian Codeine exporters with a 3.4% market share. The top 3 exporters are ADCOCK INGRAM LIMITED ($33.3M), WOCKHARDT LIMITED ($9.6M), MEDREICH LIMITED ($7.3M). Sanofi India Limited processed 75 shipments to 2 destination countries.
What Codeine Formulations Does Sanofi India Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS ( 295741 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) P | $140.3K | 3 |
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS ( 293972 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) P | $139.7K | 3 |
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS ( 295845 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PTBS | $139.1K | 3 |
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS (294673 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PA | $136.4K | 3 |
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS (294327 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PA | $135.9K | 3 |
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS (292880 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PA | $135.5K | 3 |
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS ( 196729 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PTBS | $98.7K | 3 |
| PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS (196905 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PA | $96.4K | 3 |
| PHARMACEUTICAL PRODUCTS - MERSYNDOL FORTE 5-30-450MG TABLETS (87391 PACK X 20) EXEMPTED MATERIAL (W/O WASTAGE CODEINE PHTBS | $60.7K | 3 |
| PHARMACEUTICAL PRODUCTS - MERSYNDOL FORTE 5-30-450MG TABLETS (87629 PACK X 20) Exempted Material (W/O Wastage) CODEINE P | $60.5K | 3 |
Sanofi India Limited exports 55 distinct Codeine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG T with 3 shipments worth $140.3K.
Regulatory Requirements: Exporting Codeine to Key Markets
What Sanofi India Limited must comply with to export Codeine to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sanofi India Limited Compare to Nearest Codeine Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | WOCKHARDT LIMITED | $9.6M | 191 | 1 | $50.0K |
| 3 | MEDREICH LIMITED | $7.3M | 145 | 4 | $50.0K |
| 4 | SANOFI INDIA LIMITED ★ | $3.8M | 75 | 2 | $50.0K |
| 6 | CIPLA LIMITED | $1.4M | 211 | 3 | $6.7K |
| 5 | PRG PHARMA PRIVATE LIMITED | $750.0K | 15 | 2 | $50.0K |
Sanofi India Limited ranks #4 among 30 Indian Codeine exporters. Average shipment value of $50.0K compared to the market average of $2.0M. The closest competitors by value are WOCKHARDT LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Codeine Exports?
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 657 | 36.8% |
| BANGALORE ICD (INWFD6) | 205 | 11.5% |
| NHAVA SHEVA SEA (INNSA1) | 171 | 9.6% |
| JNPT/ NHAVA SHEVA SEA | 135 | 7.6% |
| JNPT | 114 | 6.4% |
| SAHAR AIR | 80 | 4.5% |
| Bangalore | 59 | 3.3% |
| Bangalore ICD | 34 | 1.9% |
Geopolitical & Trade Policy Impact on Sanofi India Limited's Codeine Exports
Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Sanofi India. The escalation of conflicts in the Middle East, particularly around the Red Sea and Suez Canal, has disrupted key shipping routes. Major carriers have suspended or restricted transits, leading to extended transit times by 10–20 days and increased freight rates by 40–50% on India–Europe routes. (livemint.com) These disruptions pose risks to the timely delivery of temperature-sensitive pharmaceuticals, potentially affecting product efficacy and market competitiveness.
In the United States, the implementation of tariffs on pharmaceutical imports, including a 25% reciprocal tariff and an additional 25% penalty tied to India's energy policies, has created an uncertain trade environment. Although pharmaceuticals have been exempt from some of these tariffs, the potential for future escalations remains a concern. (en.wikipedia.org) Additionally, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures, adding complexity to market entry and sustainability for exporters like Sanofi India.
Sanofi India Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Sanofi India has consistently adhered to guidelines set by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). This commitment ensures product quality and facilitates access to global markets. However, evolving regulatory requirements, such as the EU's Falsified Medicines Directive, demand continuous adaptation and investment in compliance infrastructure. For instance, the directive's serialization and traceability mandates require significant technological upgrades, impacting operational costs and necessitating strategic planning.
About Sanofi India Limited
Sanofi India Limited exports 4 products worth $9.0M. Beyond Codeine, top products include Ramipril, Insulin, Teicoplanin. View the complete Sanofi India Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Codeine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Codeine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sanofi India Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 75 individual customs records matching Sanofi India Limited exporting Codeine, covering 55 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 35+ countries, 82+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Codeine Export Data from Sanofi India Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sanofi India Limited's Codeine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sanofi India Limited
Full Company Profile →
4 products · $9.0M total trade · 4 categories
Codeine Stats
Company Overview
Top Products by Sanofi India Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sanofi India Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Codeine. For current shipment-level data, contact TransData Nexus.